GLUT10 is required for the development of the cardiovascular system and the notochord and connects mitochondrial function to TGFβ signaling

Human Molecular Genetics

Volumn 21, Issue 6, 2012, Pages 1248-1259

  Willaert, Andy ^a,b   Khatri, Sandeep ^c   Callewaert, Bert L ^a,b   Coucke, Paul J ^b   Crosby, Seth D ^a   Lee, Joseph G H ^f   Davis, Elaine C ^f   Shiva, Sruti ^d,e   Tsang, Michael ^e   De paepe, Anne ^b   Urban, Zsolt ^a,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d Vascular Medicine Institute   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 10 PROTEIN; OLIGONUCLEOTIDE; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNCLASSIFIED DRUG;

ARTICLE; BLOOD FLOW; BREATHING; CARDIOVASCULAR MALFORMATION; CARDIOVASCULAR SYSTEM; DEVELOPMENT; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EMBRYO; GENE ACTIVITY; GENE CONTROL; GENE SILENCING; GENETIC ANALYSIS; HEART RATE; MITOCHONDRIAL RESPIRATION; NONHUMAN; NOTOCHORD; ORGANOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ZEBRA FISH;

AMINO ACID SEQUENCE; ANIMALS; CARDIOVASCULAR ABNORMALITIES; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; LUCIFERASES; MITOCHONDRIA; MOLECULAR SEQUENCE DATA; MORPHOLINOS; MUTATION; NOTOCHORD; PHENOTYPE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA; ZEBRAFISH;

DANIO RERIO;

EID: 84863229358     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr555     Document Type: Article

References (48)

1. Ma, X.M. and Blenis, J. (2009) Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell Biol., 10, 307-318.
2. Goumans, M.J., Liu, Z. and ten Dijke, P. (2009) TGF-beta signaling in vascular biology and dysfunction. Cell Res., 19, 116-127.
3. Nian, M., Lee, P., Khaper, N. and Liu, P. (2004) Inflammatory cytokines and postmyocardial infarction remodeling. Circ. Res., 94, 1543-1553.
4. Hayden, M.R. and Reidy, M. (1995) Many roads lead to atheroma. Nat. Med., 1, 22-23.
5. Callewaert, B.L., Willaert, A., Kerstjens-Frederikse, W.S., De Backer, J., Devriendt, K., Albrecht, B., Ramos-Arroyo, M.A., Doco-Fenzy, M., Hennekam, R.C., Pyeritz, R.E. et al. (2008) Arterial tortuosity syndrome: clinical and molecular findings in 12 newly identified families. Hum. Mutat., 29, 150-158.
6. Coucke, P.J., Willaert, A., Wessels, M.W., Callewaert, B., Zoppi, N., De Backer, J., Fox, J.E., Mancini, G.M., Kambouris, M., Gardella, R. et al. (2006) Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome. Nat. Genet., 38, 452-457.
7. Neptune, E.R., Frischmeyer, P.A., Arking, D.E., Myers, L., Bunton, T.E., Gayraud, B., Ramirez, F., Sakai, L.Y. and Dietz, H.C. (2003) Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat. Genet., 33, 407-411.
8. Loeys, B.L., Chen, J., Neptune, E.R., Judge, D.P., Podowski, M., Holm, T., Meyers, J., Leitch, C.C., Katsanis, N., Sharifi, N. et al. (2005) A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat. Genet., 37, 275-281.
9. Hucthagowder, V., Sausgruber, N., Kim, K.H., Angle, B., Marmorstein, L.Y. and Urban, Z. (2006) Fibulin-4: a novel gene for an autosomal recessive cutis laxa syndrome. Am. J. Hum. Genet., 78, 1075-1080.
10. Renard, M., Holm, T., Veith, R., Callewaert, B.L., Ades, L.C., Baspinar, O., Pickart, A., Dasouki, M., Hoyer, J., Rauch, A. et al. (2010) Altered TGFbeta signaling and cardiovascular manifestations in patients with autosomal recessive cutis laxa type I caused by fibulin-4 deficiency. Eur. J. Hum. Genet., 18, 895-901.
11. Cohn, R.D., van Erp, C., Habashi, J.P., Soleimani, A.A., Klein, E.C., Lisi, M.T., Gamradt, M., ap Rhys, C.M., Holm, T.M., Loeys, B.L. et al. (2007) Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nat. Med., 13, 204-210.
12. Habashi, J.P., Judge, D.P., Holm, T.M., Cohn, R.D., Loeys, B.L., Cooper, T.K., Myers, L., Klein, E.C., Liu, G., Calvi, C. et al. (2006) Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science, 312, 117-121.
13. Callewaert, B.L., Loeys, B.L., Casteleyn, C., Willaert, A., Dewint, P., De Backer, J., Sedlmeier, R., Simoens, P., De Paepe, A.M. and Coucke, P.J. (2008) Absence of arterial phenotype in mice with homozygous slc2A10 missense substitutions. Genesis, 46, 385-389.
14. Cheng, C.H., Kikuchi, T., Chen, Y.H., Sabbagha, N.G., Lee, Y.C., Pan, H.J., Chang, C. and Chen, Y.T. (2009) Mutations in the SLC2A10 gene cause arterial abnormalities in mice. Cardiovasc. Res., 81, 381-388.
15. Chico, T.J., Ingham, P.W. and Crossman, D.C. (2008) Modeling cardiovascular disease in the zebrafish. Trends Cardiovasc. Med., 18, 150-155.
16. Chiarelli, N., Ritelli, M., Zoppi, N., Benini, A., Borsani, G., Barlati, S. and Colombi, M. (2011) Characterization and expression pattern analysis of the facilitative glucose transporter 10 gene (slc2a10) in Danio rerio. Int. J. Dev. Biol., 55, 229-236.
17. Thisse, C. and Zon, L.I. (2002) Organogenesis-heart and blood formation from the zebrafish point of view. Science, 295, 457-462.
18. Li, H.Y., Wang, Y., Heap, C.R., King, C.H., Mundla, S.R., Voss, M., Clawson, D.K., Yan, L., Campbell, R.M., Anderson, B.D. et al. (2006) Dihydropyrrolopyrazole transforming growth factor-beta type I receptor kinase domain inhibitors: a novel benzimidazole series with selectivity versus transforming growth factor-beta type II receptor kinase and mixed lineage kinase-7. J. Med. Chem., 49, 2138-2142.
19. Singh, J., Chuaqui, C.E., Boriack-Sjodin, P.A., Lee, W.C., Pontz, T., Corbley, M.J., Cheung, H.K., Arduini, R.M., Mead, J.N., Newman, M.N. et al. (2003) Successful shape-based virtual screening: the discovery of a potent inhibitor of the type I TGFbeta receptor kinase (TbetaRI). Bioorg. Med. Chem. Lett., 13, 4355-4359.
20. Lowell, B.B. and Spiegelman, B.M. (2000) Towards a molecular understanding of adaptive thermogenesis. Nature, 404, 652-660.
21. Wrana, J.L., Attisano, L., Carcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X.F. and Massague, J. (1992) TGF beta signals through a heteromeric protein kinase receptor complex. Cell, 71, 1003-1014.
22. Park, S.O., Lee, Y.J., Seki, T., Hong, K.H., Fliess, N., Jiang, Z., Park, A., Wu, X., Kaartinen, V., Roman, B.L. et al. (2008) ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2. Blood, 111, 633-642.
23. Sumanas, S. and Larson, J.D. (2002) Morpholino phosphorodiamidate oligonucleotides in zebrafish: a recipe for functional genomics? Brief Funct. Genomic Proteomic., 1, 239-256.
24. Fouquet, B., Weinstein, B.M., Serluca, F.C. and Fishman, M.C. (1997) Vessel patterning in the embryo of the zebrafish: guidance by notochord. Dev. Biol., 183, 37-48.
25. Christiansen, H.E., Lang, M.R., Pace, J.M. and Parichy, D.M. (2009) Critical early roles for col27a1a and col27a1b in zebrafish notochord morphogenesis, vertebral mineralization and post-embryonic axial growth. PLoS One, 4, e8481.
26. Hu, Q., Shifren, A., Sens, C., Choi, J., Szabo, Z., Starcher, B.C., Knutsen, R.H., Shipley, J.M., Davis, E.C., Mecham, R.P. et al. (2010) Mechanisms of emphysema in autosomal dominant cutis laxa. Matrix Biol., 29, 621-628.
27. Gomes, F.C., Sousa Vde, O. and Romao, L. (2005) Emerging roles for TGF-beta1 in nervous system development. Int. J. Dev. Neurosci., 23, 413-424.
28. Lin, Z., Willers, C., Xu, J. and Zheng, M.H. (2006) The chondrocyte: biology and clinical application. Tissue Eng., 12, 1971-1984.
29. Saika, S. (2006) TGFbeta pathobiology in the eye. Lab Invest, 86, 106-115.
30. Carvalho, R.L., Itoh, F., Goumans, M.J., Lebrin, F., Kato, M., Takahashi, S., Ema, M., Itoh, S., van Rooijen, M., Bertolino, P. et al. (2007) Compensatory signalling induced in the yolk sac vasculature by deletion of TGFbeta receptors in mice. J. Cell Sci., 120, 4269-4277.
31. Pletcher, B.A., Fox, J.E., Boxer, R.A., Singh, S., Blumenthal, D., Cohen, T., Brunson, S., Tafreshi, P. and Kahn, E. (1996) Four sibs with arterial tortuosity: description and review of the literature. Am. J. Med. Genet., 66, 121-128.
32. Wipff, P.J., Rifkin, D.B., Meister, J.J. and Hinz, B. (2007) Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J. Cell Biol., 179, 1311-1323.
33. Lee, Y.C., Huang, H.Y., Chang, C.J., Cheng, C.H. and Chen, Y.T. (2010) Mitochondrial GLUT10 facilitates dehydroascorbic acid import and protects cells against oxidative stress: mechanistic insight into arterial tortuosity syndrome. Hum. Mol. Genet., 19, 3721-3733.
34. Dabrowski, K. (1990) Gulonolactone oxidase is missing in teleost fish. The direct spectrophotometric assay. Biol. Chem. Hoppe Seyler, 371, 207-214.
35. de Cavanagh, E.M., Ferder, M., Inserra, F. and Ferder, L. (2009) Angiotensin II, mitochondria, cytoskeletal, and extracellular matrix connections: an integrating viewpoint. Am. J. Physiol. Heart Circ. Physiol., 296, H550-H558.
36. Guo, P., Nishiyama, A., Rahman, M., Nagai, Y., Noma, T., Namba, T., Ishizawa, M., Murakami, K., Miyatake, A., Kimura, S. et al. (2006) Contribution of reactive oxygen species to the pathogenesis of left ventricular failure in Dahl salt-sensitive hypertensive rats: effects of angiotensin II blockade. J. Hypertens., 24, 1097-1104.
37. Mitchell, C., Robin, M.A., Mayeuf, A., Mahrouf-Yorgov, M., Mansouri, A., Hamard, M., Couton, D., Fromenty, B. and Gilgenkrantz, H. (2009) Protection against hepatocyte mitochondrial dysfunction delays fibrosis progression in mice. Am. J. Pathol., 175, 1929-1937.
38. Zhao, W., Zhao, T., Chen, Y., Ahokas, R.A. and Sun, Y. (2008) Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats. Mol. Cell Biochem., 317, 43-50.
39. Campbell, S.E. and Katwa, L.C. (1997) Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts. J. Mol. Cell Cardiol., 29, 1947-1958.
40. Schultz Jel, J., Witt, S.A., Glascock, B.J., Nieman, M.L., Reiser, P.J., Nix, S.L., Kimball, T.R. and Doetschman, T. (2002) TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. J. Clin. Invest., 109, 787-796.
41. Reversade, B., Escande-Beillard, N., Dimopoulou, A., Fischer, B., Chng, S.C., Li, Y., Shboul, M., Tham, P.Y., Kayserili, H., Al-Gazali, L. et al. (2009) Mutations in PYCR1 cause cutis laxa with progeroid features. Nat. Genet., 41, 1016-1021.
42. Hellemans, J., Mortier, G., De Paepe, A., Speleman, F. and Vandesompele, J. (2007) qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol., 8, R19.
43. McCurley, A.T. and Callard, G.V. (2008) Characterization of housekeeping genes in zebrafish: male-female differences and effects of tissue type, developmental stage and chemical treatment. BMC Mol. Biol., 9, 102.
44. Murphey, R.D. and Zon, L.I. (2006) Small molecule screening in the zebrafish. Methods, 39, 255-261.
45. Davis, E.C. (1993) Smooth muscle cell to elastic lamina connections in developing mouse aorta. Role in aortic medial organization. Lab. Invest., 68, 89-99.
46. Larkin, M.A., Blackshields, G., Brown, N.P., Chenna, R., McGettigan, P.A., McWilliam, H., Valentin, F., Wallace, I.M., Wilm, A., Lopez, R. et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics, 23, 2947-2948.
47. Dawson, P.A., Mychaleckyj, J.C., Fossey, S.C., Mihic, S.J., Craddock, A.L. and Bowden, D.W. (2001) Sequence and functional analysis of GLUT10: a glucose transporter in the Type 2 diabetes-linked region of chromosome 20q12-13.1. Mol. Genet. Metab., 74, 186-199.
48. Joost, H.G. and Thorens, B. (2001) The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review). Mol. Membr Biol., 18, 247-256.